Genomic and immunological profiling reveals novel prognostic biomarkers for limited-stage small cell lung cancer.

Discov Oncol · 2025 · PMC12181571 · PMID 40542277

Europe PMC DOI

hedged sentence

0.0530

closest p · 1.1× alpha

0.0530

boldest claim

The sentences

a favorable trendP = 0.053so close (0.05 < p ≤ 0.1)

Moreover, PD-L1 negative patients who did not undergo adjuvant chemotherapy exhibited significantly improved OS ( P = 0.029) and a favorable trend in DFS ( P = 0.053) compared to those who underwent adjuvant chemotherapy.

also in 466 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.